News
Articles
GHC Genetics first to test newly discovered genes linked to breast cancer risk
In August 2023, a team of researchers from Canada and Europe came up with the discovery of new genes that are also linked to an increased risk of breast cancer. The genes are MAP3K1, LZTR1, ATR and BARD1. The GHC Genetics laboratory was the first in the Czech Republic to include testing for these genes in its oncogenetic panel, which analyses risk genes associated with certain inherited diseases, particularly breast and ovarian cancer, but also other cancers.
This year marks 70 years since the discovery of the structure of DNA
Deoxyribonucleic acid (DNA) is the basic building block of life on our planet and the carrier of the hereditary characteristics of all living organisms. There is no doubt that the discovery of its double-helix structure by Francis Crick and James Watson 70 years ago, presented in April 1953, was one of the greatest scientific breakthroughs of the 20th century, transforming many other fields and leading to other important discoveries and projects, such as the mapping of the entire human genome, which was completed in 2022. Let us recall the path that led to the discovery of the structure of DNA.
GHC Genetics is a general partner of the DOBA GENOVÁ exhibition
GHC Genetics has become a general partner of the travelling exhibition "DOBA GENOVÁ", organised by Asgent and other professional institutions. The purpose of the exhibition is to present the mysteries of DNA and human genetics in a simple and entertaining way in relation to rare genetic diseases, their diagnosis and possible treatment. GHC Genetics has provided copies of unique documents relating to the discovery of the structure of DNA made 70 years ago.